BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dai Z, Zhang J, Wu Q, Fang H, Shi C, Li Z, Lin C, Tang D, Wang D. Intestinal microbiota: a new force in cancer immunotherapy. Cell Commun Signal 2020;18:90. [PMID: 32522267 DOI: 10.1186/s12964-020-00599-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 16.5] [Reference Citation Analysis]
Number Citing Articles
1 Zidane M, Theurich S, Schlaak M. Malignes Melanom und Adipositas: eine Übersichtsarbeit. Adipositas - Ursachen, Folgeerkrankungen, Therapie 2022;16:220-227. [DOI: 10.1055/a-1849-6722] [Reference Citation Analysis]
2 Chen Y, Yeh Y, Su Y, Liao C, Huang C, Cheng Y, Jan J. Cell adhesion inhibiting peptides exhibit potent anticancer activity and modulate intestinal microbiota. Materials & Design 2022;224:111303. [DOI: 10.1016/j.matdes.2022.111303] [Reference Citation Analysis]
3 Jin M, Wu J, Shi L, Zhou B, Shang F, Chang X, Dong X, Deng S, Liu L, Cai K, Nie X, Zhang T, Fan J, Liu H. Gut microbiota distinct between colorectal cancers with deficient and proficient mismatch repair: A study of 230 CRC patients. Front Microbiol 2022;13:993285. [DOI: 10.3389/fmicb.2022.993285] [Reference Citation Analysis]
4 Dai Z, Fu J, Peng X, Tang D, Song J. Intestinal Microbiota: The Driving Force behind Advances in Cancer Immunotherapy. Cancers (Basel) 2022;14:4796. [PMID: 36230724 DOI: 10.3390/cancers14194796] [Reference Citation Analysis]
5 Messaritakis I, Koulouridi A, Boukla E, Sfakianaki M, Vogiatzoglou K, Karagianni M, Gouvas N, Tsiaoussis J, Xynos E, Athanasakis E, Mavroudis D, Tzardi M, Souglakos J. Investigation of Microbial Translocation, TLR and VDR Gene Polymorphisms, and Recurrence Risk in Stage III Colorectal Cancer Patients. Cancers (Basel) 2022;14:4407. [PMID: 36139567 DOI: 10.3390/cancers14184407] [Reference Citation Analysis]
6 Aghamajidi A, Maleki Vareki S. The Effect of the Gut Microbiota on Systemic and Anti-Tumor Immunity and Response to Systemic Therapy against Cancer. Cancers 2022;14:3563. [DOI: 10.3390/cancers14153563] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Raza A, Rossi GR, Janjua TI, Souza-Fonseca-Guimaraes F, Popat A. Nanobiomaterials to modulate natural killer cell responses for effective cancer immunotherapy. Trends Biotechnol 2022:S0167-7799(22)00151-2. [PMID: 35840426 DOI: 10.1016/j.tibtech.2022.06.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Xu X, Ying J. Gut Microbiota and Immunotherapy. Front Microbiol 2022;13:945887. [DOI: 10.3389/fmicb.2022.945887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Xie YJ, Huang M, Li D, Hou JC, Liang HH, Nasim AA, Huang JM, Xie C, Leung EL, Fan XX. Bacteria-based nanodrug for anticancer therapy. Pharmacol Res 2022;:106282. [PMID: 35662630 DOI: 10.1016/j.phrs.2022.106282] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Abdel Sater AH, Bouferraa Y, Amhaz G, Haibe Y, Lakkiss AE, Shamseddine A. From Tumor Cells to Endothelium and Gut Microbiome: A Complex Interaction Favoring the Metastasis Cascade. Front Oncol 2022;12:804983. [PMID: 35600385 DOI: 10.3389/fonc.2022.804983] [Reference Citation Analysis]
11 Zhang Z, Zhang H, Chen T, Shi L, Wang D, Tang D. Regulatory role of short-chain fatty acids in inflammatory bowel disease. Cell Commun Signal 2022;20:64. [PMID: 35546404 DOI: 10.1186/s12964-022-00869-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
12 He J, Bosch TCG. Hydra’s Lasting Partnership with Microbes: The Key for Escaping Senescence? Microorganisms 2022;10:774. [DOI: 10.3390/microorganisms10040774] [Reference Citation Analysis]
13 Aru B, Soltani M, Pehlivanoglu C, Gürlü E, Ganjalikhani-Hakemi M, Yanikkaya Demirel G. Comparison of Laboratory Methods for the Clinical Follow Up of Checkpoint Blockade Therapies in Leukemia: Current Status and Challenges Ahead. Front Oncol 2022;12:789728. [PMID: 35155232 DOI: 10.3389/fonc.2022.789728] [Reference Citation Analysis]
14 Rawat P, Dhingra M, Kosta K, Das A. Microflora impacts immune system and its antitumor function. Microbial Crosstalk with Immune System 2022. [DOI: 10.1016/b978-0-323-96128-8.00007-9] [Reference Citation Analysis]
15 Sevcikova A, Izoldova N, Stevurkova V, Kasperova B, Chovanec M, Ciernikova S, Mego M. The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy. Int J Mol Sci 2022;23:488. [PMID: 35008915 DOI: 10.3390/ijms23010488] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
16 Ahlawat S, Asha, Sharma KK. Cancer therapeutics and gut microflora. Microbial Crosstalk with Immune System 2022. [DOI: 10.1016/b978-0-323-96128-8.00005-5] [Reference Citation Analysis]
17 De Silva S, Tennekoon KH, Karunanayake EH. Interaction of Gut Microbiome and Host microRNAs with the Occurrence of Colorectal and Breast Cancer and Their Impact on Patient Immunity. Onco Targets Ther 2021;14:5115-29. [PMID: 34712050 DOI: 10.2147/OTT.S329383] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 García-Sancha N, Corchado-Cobos R, Bellido-Hernández L, Román-Curto C, Cardeñoso-Álvarez E, Pérez-Losada J, Orfao A, Cañueto J. Overcoming Resistance to Immunotherapy in Advanced Cutaneous Squamous Cell Carcinoma. Cancers (Basel) 2021;13:5134. [PMID: 34680282 DOI: 10.3390/cancers13205134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Hita-Millan J, Carracedo A, Fernandez-Rozadilla C. Liquid Biopsy Biomarkers for Immunotherapy in Non-Small Cell Lung Carcinoma: Lessons Learned and the Road Ahead. J Pers Med 2021;11:971. [PMID: 34683113 DOI: 10.3390/jpm11100971] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Radha G, Lopus M. The spontaneous remission of cancer: Current insights and therapeutic significance. Transl Oncol 2021;14:101166. [PMID: 34242964 DOI: 10.1016/j.tranon.2021.101166] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
21 Zhang J, Dai Z, Yan C, Zhang W, Wang D, Tang D. A new biological triangle in cancer: intestinal microbiota, immune checkpoint inhibitors and antibiotics. Clin Transl Oncol 2021. [PMID: 34125407 DOI: 10.1007/s12094-021-02659-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
22 Yip HYK, Papa A. Signaling Pathways in Cancer: Therapeutic Targets, Combinatorial Treatments, and New Developments. Cells 2021;10:659. [PMID: 33809714 DOI: 10.3390/cells10030659] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 20.0] [Reference Citation Analysis]
23 Soysouvanh F, Giuliano S, Habel N, El-Hachem N, Pisibon C, Bertolotto C, Ballotti R. An Update on the Role of Ubiquitination in Melanoma Development and Therapies. J Clin Med 2021;10:1133. [PMID: 33800394 DOI: 10.3390/jcm10051133] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
24 Verdier C, Denis S, Gasc C, Boucinha L, Uriot O, Delmas D, Dore J, Le Camus C, Schwintner C, Blanquet-Diot S. An Oral FMT Capsule as Efficient as an Enema for Microbiota Reconstruction Following Disruption by Antibiotics, as Assessed in an In Vitro Human Gut Model. Microorganisms 2021;9:358. [PMID: 33670255 DOI: 10.3390/microorganisms9020358] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
25 Rosenberg E. Holistic Fitness: Microbiomes are Part of the Holobiont’s Fitness. Microbiomes 2021. [DOI: 10.1007/978-3-030-65317-0_4] [Reference Citation Analysis]
26 Koulouridi A, Messaritakis I, Gouvas N, Tsiaoussis J, Souglakos J. Immunotherapy in Solid Tumors and Gut Microbiota: The Correlation-A Special Reference to Colorectal Cancer. Cancers (Basel) 2020;13:E43. [PMID: 33375686 DOI: 10.3390/cancers13010043] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
27 Rezasoltani S, Yadegar A, Asadzadeh Aghdaei H, Reza Zali M. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors. Cancer Med 2021;10:1141-54. [PMID: 33369247 DOI: 10.1002/cam4.3694] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
28 Irfan M, Delgado RZR, Frias-Lopez J. The Oral Microbiome and Cancer. Front Immunol 2020;11:591088. [PMID: 33193429 DOI: 10.3389/fimmu.2020.591088] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 24.0] [Reference Citation Analysis]
29 Haga SB. Individualizing pharmacogenomic test results in the context of the microbiome. Per Med 2020;17:459-68. [PMID: 33026284 DOI: 10.2217/pme-2020-0077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Gallo M, Adinolfi V, Barucca V, Prinzi N, Renzelli V, Barrea L, Di Giacinto P, Ruggeri RM, Sesti F, Arvat E, Baldelli R, Arvat E, Colao A, Isidori A, Lenzi A, Baldell R, Albertelli M, Attala D, Bianchi A, Di Sarno A, Feola T, Mazziotti G, Nervo A, Pozza C, Puliani G, Razzore P, Ramponi S, Ricciardi S, Rizza L, Rota F, Sbardella E, Zatelli MC; EOLO Group. Expected and paradoxical effects of obesity on cancer treatment response. Rev Endocr Metab Disord 2020. [PMID: 33025385 DOI: 10.1007/s11154-020-09597-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]